ONO is investigating additional molecules across our four focus areas in clinical trials around the world.
Combination with nivolumab
S1P5 receptor agonist
Enhancement of Schwann cell differentiation
Our Global Pipeline
ONO is investigating additional therapeutics across our four focus areas globally.